Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (5)

« Back to Publications

Mucoactive therapies and the European Respiratory Society guideline for adult bronchiectasis: what now after the CLEAR trial?

Chalmers JD. et al, (2026), Eur Respir J, 67

Taking a wider view: The Lancet Respiratory Medicine Commission on bronchiectasis.

Chalmers JD. et al, (2026), Lancet Respir Med, 14, 291 - 294

Ten unanswered questions about dipeptidyl peptidase-1 inhibition in bronchiectasis.

He J. et al, (2026), Lancet Respir Med

Clearing the air: Clarifying data and interpretations from the ASPEN trial of brensocatib in bronchiectasis.

Chalmers JD., (2026), Med, 7

The European Respiratory Journal 2026: towards the golden age of respiratory science?

Chalmers JD. et al, (2026), Eur Respir J, 67